HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Schmitt-Hoffmann Selected Research

Oral Administration

11/2009Effect of mild and moderate liver disease on the pharmacokinetics of isavuconazole after intravenous and oral administration of a single dose of the prodrug BAL8557.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Schmitt-Hoffmann Research Topics

Disease

1Liver Diseases (Liver Disease)
11/2009
1Mycoses (Diseases, Fungus)
11/2009
1Pneumococcal Pneumonia
04/2004
1Body Weight (Weight, Body)
04/2004

Drug/Important Bio-Agent (IBA)

2ProdrugsIBA
11/2009 - 04/2004
1isavuconazoleIBA
11/2009
1Ceftriaxone (Ceftriaxon)FDA LinkGeneric
04/2004
1ceftobiprole medocarilIBA
04/2004
1ceftobiproleIBA
04/2004
1Cephalosporins (Cephalosporin Antibiotics)IBA
04/2004

Therapy/Procedure

1Oral Administration
11/2009